- Investing Ideas
- /
- South Korean Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
South Korean Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
3
0 new
High return on equity, past performance and sound balance sheet.
3 companies
SK Biopharmaceuticals
Market Cap: ₩8.7t
A pharmaceutical company, engages in the research and development of drugs for the treatment of central nervous system disorders.
A326030
₩111,000.00
7D
1.6%
1Y
6.4%
JW Lifescience
Market Cap: ₩185.0b
Provides national infusion solutions in South Korea and internationally.
A234080
₩11,950.00
7D
1.9%
1Y
8.7%
JW Shinyak
Market Cap: ₩80.7b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩1,517.00
7D
0.4%
1Y
-3.4%